Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Genezen Announces the Appointment of Steven J. Favaloro as Chief Executive Officer to Support Next Phase of Growth
Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO) specializing in lentiviral […]
Sumitovant Biopharma Completes Acquisition of Myovant Sciences
Sumitovant Biopharma and Myovant Sciences announced today that Sumitovant has successfully completed its acquisition of […]
Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of Directors
Diamyd Medical today announced that Karin Rosén will join the Board of Directors as an […]
Cell One Partners and Center for Breakthrough Medicines Announce Strategic Partnership to Accelerate Cell and Gene Therapy Commercialization
Cell One Partners, an industry-leading strategic consulting firm positioned to support cell and gene therapy […]
Allorion Therapeutics Raises $50 Million Series B Financing
Allorion Therapeutics, a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, […]
Alnylam Announces Appointment of Peter Kellogg to Board of Directors
Alnylam Pharmaceuticals, the leading RNAi therapeutics company, announced today the appointment of Peter Kellogg to […]
Aldevron and Evanoa Sign Licensing Agreement
Evanoa Bioscience, a cell line developer for biologics manufacturing, together with Aldevron, a global leader […]
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
QIAGEN today announced it has entered into a strategic partnership with Servier, a global pharmaceutical […]
Korro Bio and Genevant Sciences Enter into Collaboration Agreement to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency
Korro Bio, a leading RNA editing company focused on the discovery and development of novel […]
Biocytogen Announces RenLite™ Licensing Agreement with Janssen
Biocytogen Pharmaceuticals, have announced the signing of a non-exclusive license agreement with Janssen Biotech, one […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more